vialauditThe Roundup

affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →

VENDOR MATCHUP · AUDITED

Panda Peptides vs Peptide Partners

Two audits, side by side. Composite, subscores, shipping, payment, coupons. Panda Peptides takes the higher composite this cycle.

Composite score

HIGHER COMPOSITE
77
OF 100
VENDOR AUDIT

Panda Peptides

100 Janoshik and 24 ILS reports in a public COA hub, one AOD-9604 vial at 80% of label, and retatrutide sold under a code name. Public-data audit, 77/100.

vs
50
OF 100
VENDOR AUDIT

Peptide Partners

32 Kovera vial reports at a 99.83% median purity, three Kovera fails its own ledger omits, and open FDA warning letter 735063. Public-data audit, 50/100.

Subscore breakdown

7 METRICS
METRIC
PANDA PEPTIDES
PEPTIDE PARTNERS
Composite · weighted avg
77/100
vs
50/100
Purity / COA
80/100
vs
68/100
Shipping · domestic days
4.0d
vs
4.0d
Pricing
86/100
vs
78/100
Support
80/100
vs
45/100
Last tested
2026-10-09
vs
2026-10-09
Payment
card, ach
vs
card, wire

Catalog overlap

ONLY PANDA PEPTIDES
pt-141nad-plusglp-3glp-1sklow
BOTH
bpc-157tb-500ghk-cumots-ctesamorelin
ONLY PEPTIDE PARTNERS
retatrutidetirzepatidesemaglutidess-31epitalon

Other matchups

ALL COMPARISONS →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH